Inhibition of dopamine beta-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo.
D000311:Adrenal Glands / Q000032:analysis; D000313:Adrenal Medulla / Q000201:enzymology; D000818:Animals; D001205:Ascorbic Acid; D001923:Brain Chemistry; D002417:Cattle; D003300:Copper / Q000494:pharmacology; D003956:Dialysis; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000032:analysis; D005650:Fumarates / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D010848:Picolinic Acids / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000032:analysis; D014439:Tyramine / Q000032:analysis / Q000378:metabolism
D005650:Fumarates; D010848:Picolinic Acids; D003300:Copper; D006899:Mixed Function Oxygenases; D001205:Ascorbic Acid; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine